1. home
  2. 公司
  3. SKYER, Inc.

SKYER, Inc.

韩国

我们是谁?

For the past 100 years, the world's population has increased by 1 billion every 13 years. As the population grows, an ecosystem has been changed. The traditional buffer zones that separate humans from animals or from the pathogens that they harbor are notably reduced. And inevitably, the frequency and prevalence of these infectious diseases, defined as ‘zoonosis’, have increased. The most effective way to minimize damages from zoonotic diseases is to detect them earlier.

Born in 2010, SKYER develops and produces high-quality and highly efficient antigen-antibody reaction test kits that have shown consistent sensitivity, specificity, and accuracy. And we will continue our effort to make faster and more accurate test kits by integrating advanced materials and technologies into our system.

我们的价值观

We believe rapid tests (also known as lateral flow assays - LFAs - or immunochromatographic strip tests - ICTs), especially in the Point-of-Care Test (POCT), are crucial for managing zoonotic pandemics with the lowest cost.

SKYER pursues creative ideas, open-mindedness, infinite opportunities, and diversity to create a world where humans and nature coexist more safely.

* 显示价格为参考价,此价格不含税、不含运费、不含关税,也不包含因安装或投入使用所产生的其他额外费用。参考价格可能因国家、原材料价格和汇率的不同而产生变化。
关于 MedicalExpo
MedicalExpo是一个市场,为B2B参与者提供从产品采购到购买的完整体验。MedicalExpo是VirtualExpo Group的实体之一。